As expected, EGFR (Fig. 12B), ITGA2, KRAS, MMP9, NRAS and MAPK13 (Figures S28B, S32B–35B) had higher levels in lung adenocarcinoma than in normal lung tissues. This evidence concerns the gene EGFR and lung adenocarcinoma.